American biotechnology firm Moderna has said an independent data monitoring committee will conduct an interim review of its ongoing vaccine trials, in November. Moderna’s vaccine candidate is called mRNA.
from Hindustan Times - world https://ift.tt/37TLCEc
No comments:
Post a Comment